Explore 3 Stock Ideas & Industry Insights Download Free Report

Aurora Spine Corp

Company price
0.1 CAD -0.01 ( 13.04%)
Last update at 2026-11-04T17:52:00Z
VOLUME
2222
Market Cap
21.47M

Momentum Score

…

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. The company was founded in 2013 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.10
High
52 Week Price Range
0.23
Low
0.40
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Aurora Spine Corp develops minimally invasive expandable interbody spinal implants and related surgical instruments for fusion procedures. Long-term growth may be supported by aging populations, wider adoption of minimally invasive spine techniques and successful expansion of clinical adoption and distribution. The company may appear positioned to benefit if regulatory approvals and commercial execution progress.

Material risks include limited commercial scale and liquidity as a small-cap medical device company, regulatory and reimbursement uncertainty, strong competition from established spine-device manufacturers and execution risk in converting clinical interest into sustained sales.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
18.05M
Revenue Per Share
0.23
Gross Profit TTM
10.78M
Debt / Equity
0.69
ROE
-30.34%
Net Debt
1.93M
ROCE
-8.65%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.00M -1.68M -1.50M -2.36M -0.23M
Net income -1.00M -1.68M -1.50M -2.36M -0.23M
Selling general administrative 9.57M 6.82M 6.08M 4.99M 3.65M
Selling and marketing expenses - 0.72M 1.05M 0.80M 0.11M
Gross profit 10.63M 8.21M 7.81M 4.83M 3.47M
Reconciled depreciation 1.01M 1.05M 0.87M 0.65M 0.59M
Ebit - -1.50M -1.28M -2.55M -1.16M
Ebitda - -0.45M -0.41M -1.90M -0.57M
Depreciation and amortization - 1.05M 0.87M 0.65M 0.59M
Operating income -0.67M -1.50M -1.57M -2.71M -1.25M
Other operating expenses - 16.02M 16.22M 13.10M 9.81M
Interest expense 0.18M 0.19M 0.16M 0.16M 0.09M
Net interest income -0.18M -0.19M -0.16M -0.16M -0.09M
Income tax expense - 0.88M 0.23M 0.16M 0.09M
Total revenue 17.56M 14.52M 14.88M 10.54M 8.65M
Total operating expenses 18.24M 9.71M 9.15M 7.38M 4.63M
Cost of revenue 6.93M 6.31M 7.07M 5.71M 5.18M
Total other income expense net -0.15M -0.19M 0.01M 0.35M 1.02M
Net income from continuing ops -1.00M -1.68M -1.50M -2.36M -0.23M
Net income applicable to common shares - - - -2.36M -0.23M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 11.67M 11.99M 10.12M 10.56M 7.16M
Intangible assets 0.80M 0.75M 0.88M 0.85M 0.87M
Other current assets - 0.20M - - -
Total liab 7.28M 6.69M 5.81M 4.99M 3.87M
Total stockholder equity 4.40M 5.30M 4.32M 5.57M 3.28M
Other current liab 0.00M - - - -
Common stock - 27.66M - 25.09M 22.01M
Capital stock 27.66M 27.66M 25.22M 25.09M 22.01M
Retained earnings -26.78M -25.78M -24.09M -22.59M -20.23M
Cash 0.78M 0.77M 0.42M 3.17M 1.71M
Total current liabilities 3.88M 3.27M 3.03M 2.63M 1.56M
Net debt 1.93M 2.88M 1.99M - 0.46M
Short term debt - 0.23M - - -
Short long term debt - - - 0.01M 0.03M
Short long term debt total - 3.65M - - -
Other stockholder equity - 3.42M - 3.08M 1.51M
Property plant equipment - - - 1.30M 1.09M
Total current assets 8.50M 8.50M 7.33M 8.41M 5.20M
Net tangible assets - - - 4.71M 2.41M
Net receivables 3.14M 3.97M 3.67M 2.67M 1.66M
Long term debt 2.71M 2.56M 2.42M 2.27M 2.14M
Inventory 3.61M 3.56M 3.05M 1.89M 1.60M
Accounts payable 1.76M 3.04M 2.83M 2.45M 1.53M
Non currrent assets other -0.00M 0.45M - - -
Non current assets total 3.17M 3.48M 2.79M 2.16M 1.96M
Capital lease obligations 0.97M 1.08M 0.55M 0.09M 0.17M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.48M -0.48M -0.87M -0.72M -0.55M
Change to liabilities - - - 1.04M -0.40M
Total cashflows from investing activities - - - -0.72M -0.55M
Net borrowings -0.36M - - -0.19M -0.14M
Total cash from financing activities -0.36M 1.76M -0.32M 4.31M 1.51M
Change to operating activities - - - -0.44M 0.03M
Net income -1.00M -1.68M -1.50M -2.36M -0.23M
Change in cash 0.06M 0.34M -2.75M 1.46M 1.27M
Begin period cash flow 0.77M 0.42M 3.17M 1.71M 0.44M
End period cash flow 0.83M 0.77M 0.42M 3.17M 1.71M
Total cash from operating activities 0.90M -0.94M -1.56M -2.13M 0.31M
Issuance of capital stock 0.00M 1.41M 0.00M 5.12M 1.70M
Depreciation 1.01M 1.05M 0.87M 0.65M 0.59M
Change to inventory -0.05M -0.51M -1.16M -0.33M -0.32M
Change to account receivables - - - -1.01M 0.78M
Other cashflows from financing activities - -0.07M 0.10M -0.64M -0.08M
Change to netincome - - - 0.33M -0.14M
Capital expenditures 0.64M 0.48M 0.87M 0.72M 0.55M
Change in working capital 0.62M -0.62M -1.36M -0.74M 0.10M
Stock based compensation 0.10M 0.14M 0.14M 0.14M 0.09M
Other non cash items 0.17M 0.18M 0.23M 0.14M -0.49M
Free cash flow 0.27M -1.41M -2.43M -2.85M -0.25M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ASG
Aurora Spine Corp
-0.01
13.04%
0.10 - - 1.19 4.07 1.02 202.96
TLT
Theralase Technologies Inc.
0.01
2.78%
0.18 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.
-0.01
4.55%
0.10 - - 66.65 - 95.30 -
PINK
Perimeter Medical Imaging AI Inc
-
-%
0.18 4.13 - 18.78 11.34 20.22 -2.55
CHER
Cheelcare Inc.
-
-%
1.25 - - 20.92 106.42 21.26 -

Profile*

Aurora Spine Corp

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. The company was founded in 2013 and is headquartered in Toronto, Canada.

20 Holly Street, Toronto, ON, Canada, M4S 3B1

760-424-2004

Name Title Year Born
Mr. Trent J. Northcutt Founder, Pres, CEO & Director 1967
Mr. Chad Clouse Chief Financial Officer NA
Mr. Laszlo Garamszegi CTO & Founder 1971
Mr. David M. Meyer VP, Chief Legal Officer & Sec. NA
Mr. Trent J. Northcutt Founder, President, CEO & Director 1967
Mr. David M. Meyer VP, Chief Legal Officer & Secretary NA
Matthew Goldstone Chief Commercial Officer NA
Mr. Matt Paxton Executive Vice President of Sales NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…